share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144：擬議出售證券
美股sec公告 ·  06/12 22:01
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 7,288 shares of common stock on 06/12/2024, with an aggregate market value of approximately $3,483,664. The shares were acquired on 06/10/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Morrow in the past three months, as per the latest filings.
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 7,288 shares of common stock on 06/12/2024, with an aggregate market value of approximately $3,483,664. The shares were acquired on 06/10/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Morrow in the past three months, as per the latest filings.
Vertex Pharmaceuticals Inc.的高管Atkinson Edward Morrow III將在2024年06月12日出售7,288股普通股，市值約爲$3,483,664。這些股票是作爲發行方的補償計劃的限制性股票兌現，於2024年06月10日獲得的。根據最新文件，這筆交易是在過去三個月中Morrow未出售任何證券之後進行的。
Vertex Pharmaceuticals Inc.的高管Atkinson Edward Morrow III將在2024年06月12日出售7,288股普通股，市值約爲$3,483,664。這些股票是作爲發行方的補償計劃的限制性股票兌現，於2024年06月10日獲得的。根據最新文件，這筆交易是在過去三個月中Morrow未出售任何證券之後進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。